spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  AAT  

 HSMN NewsFeed - 3 Mar 2022
Inhibrx Receives FDA Orphan-Drug Designation for INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Apr 2019
CSL Behring Delivers on its Continued Commitment to Alpha 1 Patients with FDA Approval of Convenient Single-Vial Dosing for ZEMAIRA(R) [Alpha1-Proteinase Inhibitor (Human)]
Biopharmaceuticals FDA Product Launch
 HSMN NewsFeed - 8 Feb 2017
Kamada Announces Appointment of Biopharmaceutical Industry Veteran, Gwen Melincoff, to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Oct 2016
Kamada Announces Extension of GLASSIA(R) Supply and Distribution Agreement with Shire with Minimum $237 Million of Revenue for the Years 2017 to 2020
Biopharmaceuticals Distribution Licensing
 HSMN NewsFeed - 29 Sep 2016
Amgen And Arrowhead Pharmaceuticals Announce Two Cardiovascular Collaborations
Biopharmaceuticals Licensing
 HSMN NewsFeed - 29 Sep 2016
Avita Medical Signs Exclusive Distributor Deal in Iran
Devices Regenerative Medicine Distribution
 HSMN NewsFeed - 1 Sep 2016
Kamada and Kedrion Seek FDA Approval of Human Rabies Immunoglobulin as a Post-Exposure Treatment
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Aug 2016
Arrowhead Pharmaceuticals Closes $45 Million Private Offering
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 May 2016
Hologic Introduces the MyoSure(R) REACH Device to Help Physicians Access the Hard-to-Reach Upper Third of the Uterine Cavity
Devices Product Launch
 HSMN NewsFeed - 5 May 2016
Investigational Gene-Based Therapy for Alpha-1 Antitrypsin (AAT) Deficiency Demonstrates Durable Response at Five Years
Biopharmaceuticals
 HSMN NewsFeed - 2 Jul 2014
Alnylam Elects Amy Schulman to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jan 2014
Alnylam and Genzyme Form Transformational Alliance for RNAi Therapeutics as Genetic Medicines
Biopharmaceuticals Licensing
 HSMN NewsFeed - 9 Dec 2013
Kamada Announces Appointment of Amir London as Senior Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Dec 2012
Omni Bio Pharmaceutical Appoints New CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Feb 2011
Omni Bio Pharmaceutical Realigns Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Dec 2010
Johnson & Johnson Launches Recommended Public Offer to Acquire Crucell
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Aug 2010
Baxter Announces Manufacturing, Supply and Distribution Agreement with Kamada for GLASSIA
Biopharmaceuticals Distribution
 HSMN NewsFeed - 28 Jun 2010
Abbott Receives FDA Clearance for Molecular Diagnostic Test for Detection of Chlamydia and Gonorrhea Infections
Diagnostics FDA
 HSMN NewsFeed - 7 Jun 2010
ULURU Inc. Announces Senior Management Change
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Apr 2010
ULURU Inc. Announces the Appointment of Dr. Jeffrey A. Stone to the Board of Directors
Biopharmaceuticals Drug Delivery Wound Care Personnel
 HSMN NewsFeed - 19 Oct 2009
Talecris Biotherapeutics Receives FDA Approval for PROLASTIN(R)-C
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Sep 2009
ULURU Inc. Presents Data on Negative Pressure Related to Altrazeal(TM) at the Diabetic Limb Salvage Conference in Washington, D.C.
Devices Wound Care
 HSMN NewsFeed - 16 Sep 2009
ULURU Inc. Presents Results of First Randomized Clinical Trial for Altrazeal(TM) at the Symposium on Advanced Wound Care (SAWC) Fall Meeting in Washington D.C.
Devices Wound Care
 HSMN NewsFeed - 5 May 2009
ULURU Inc. Announces Altrazeal(TM) Clinical Experience Published in the International Wound Journal
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 6 Apr 2009
ULURU Inc. Signs Offer Letter to Acquire York Pharma plc
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Mar 2009
ULURU Inc. Announces Senior Management Change
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jul 2008
Talecris Biotherapeutics Receives Orphan Drug Designation for Aerosolized Form of Alpha1-Antitrypsin (AAT) From the European Commission
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 30 Jun 2008
Nucletron Appoints New Chief Executive Officer
Devices Oncology Personnel
 HSMN NewsFeed - 2 Apr 2008
Kamada Announces That It Had Successfully Met the Primary Endpoint in Its US Phase III Clinical Trial with Intravenous AAT
Biopharmaceuticals
 HSMN NewsFeed - 13 Mar 2008
Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis
Biopharmaceuticals
 HSMN NewsFeed - 21 Feb 2008
Talecris Biotherapeutics Celebrates 20th Anniversary of Launch of Prolastin(R)
Biopharmaceuticals
 HSMN NewsFeed - 20 Feb 2008
ULURU Inc. Provides Details On Altrazeal(TM) Launch
Devices Wound Care
 HSMN NewsFeed - 14 Dec 2007
Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 Sep 2007
ULURU Inc. Announces the Appointment of Renaat Van den Hooff to Join Executive Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Sep 2007
Study Demonstrates Aerosolized Prolastin(R) Using Unique Nebulizer Results in High Levels of Drug Deposited in Peripheral Regions of Lungs
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 17 Jul 2007
Neurochem receives approvable letter for eprodisate (KIACTA(TM)) for treatment of AA amyloidosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Jun 2007
Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA(TM)) Treatment for Patients with Amyloid A (AA) Amyloidosis
Biopharmaceuticals
 HSMN NewsFeed - 11 Oct 2006
Osta Announces Promising Clinical Results on Blood Tests for Parkinson's Disease & Alzheimer's Disease
Diagnostics Neurology
 HSMN NewsFeed - 5 Sep 2006
Extensive Post-License Data Reaffirm Clinical Safety Profile of Prolastin(R)
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 10

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 10 additional stories matching:
AAT
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.